← Leaderboards
Steve Seev Sommer
City Of Hope/Beckman Research Institute
$5,682,536
Attributed
$5,682,536
Total exposure
10
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $840.7K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$5,682,536 · 10
By mechanism
R01$2,657,828 · 3
R33$1,881,976 · 1
R21$482,850 · 2
R43$355,006 · 1
R41$215,235 · 1
R03$87,500 · 1
Top collaborators
No co-investigators on record.
Most similar at City Of Hope/Beckman Research Institute
Same institution · by research overlap
- Lawrence M. Weiss$1,112,993
- Marcia M Miller$591,202
Others in their field
Top investigators on “Gene Mutation”
- Richard A Gibbs · Baylor College Of Medicine$176,620,766
- David Heimbrook · Leidos Biomedical Research, Inc.$153,133,561
- Stacey Gabriel · Massachusetts Institute Of Technology$95,141,374
- Eric Martin McDade · Washington University$94,632,845
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$90,831,407
- Leonard Freedman · Leidos Biomedical Research, Inc.$79,171,841
Research focus
Gene MutationGene FrequencyAge DifferenceGenetically Modified AnimalsClinical ResearchLaboratory MouseNucleic Acid SequenceOxidative StressNutrition Related Neoplasm /CancerPeroxidationGene TargetingDiet TherapyNutrition Related TagCaroteneMutagensCancer PreventionAscorbateDietary ConstituentAnimal Genetic Material TagCarcinogenesisDietary SupplementsNeoplastic ProcessAntioxidantsTocopherols
Grant awards (17)
Monitoring of Therapy or Recurrence in Breast Cancer with Cancer-specific Mutatio$355,006
R43 · FY2010 · CA · contact PI
PAP: a technology platform$625,468
R33 · FY2006 · CA · contact PI
Highly-Multiplexed Accurate HLA Typing using PAP and Digital Bead Technologies$215,235
R41 · FY2006 · HL · contact PI
PAP: a technology platform$633,086
R33 · FY2005 · CA
PAP: a technology platform$623,422
R33 · FY2004 · CA
Tissue-Specific Antioxidant Antimutagenesis$393,750
R01 · FY2004 · AG
Restoration of Factor VIII/IX Function in Hemophilia A/B Patients with Nonsense$2,141
M01 · FY2004 · RR
Tissue-Specific Antioxidant Antimutagenesis$393,750
R01 · FY2003 · AG
Translational Bypass in Patients with Hemophilia$350,000
R01 · FY2003 · HL
Artificial Nanotube Gels for Mutation Detection$145,050
R21 · FY2003 · CA
Tissue-Specific Antioxidant Antimutagenesis$393,750
R01 · FY2002 · AG
Translational Bypass in Patients with Hemophilia$350,000
R01 · FY2002 · HL
PAP: a technology platform$175,000
R21 · FY2002 · CA
Carbon Nanotubes: Artifical Gels for Mutations Detection$162,800
R21 · FY2002 · CA
Aging and Mutation Load in Transgenic Medaka Fish$87,500
R03 · FY2002 · AG
Tissue-Specific Antioxidant Antimutagenesis$393,750
R01 · FY2001 · AG
FACTORS AFFECTING SOMATIC MUTATION--FOCUS ON THE BRAIN$382,828
R01 · FY2000 · NS